Stanley Roberts

Dr. Roberts is a pharmaceutical toxicologist with over 29 years of conducting and leading research in toxicology, drug metabolism and pharmacokinetics. He is an experienced executive in small biotech and large pharmaceutical companies (Vice President – Preclinical Development at CovX Research, LLC, Global Director – Preclinical Drug Metabolism and PK at Abbott Laboratories, and Section Head – Department of Toxicology at Sandoz Research Institute) with proven success for process improvement, innovative management and broad based integration of scientific disciplines to more efficiently identify the best new candidate compounds for further development. Dr. Roberts has demonstrated excellence in drug development across a broad range of therapeutic classes, targets, and disease areas with scientific and regulatory experience in both small molecules and biotherapeutics (e.g., peptides, proteins and antibodies) with direct and significant contributions to numerous registration packages including designing, monitoring and reporting studies plus composing and editing position papers and submission packages. He has a MS and PhD in Pharmacology and Toxicology from Purdue University.